Penpulimab in combination therapy for the first-line treatment of metastatic NPC, has had its marketing application accepted by the NMPA and the FDA. Additionally, the marketing application for its ...

Christopher Burge is one of a growing number of young adults diagnosed with the disease, and hopes to spread awareness about the early signs.

Sarrah Strimel Bentley is an optimist – even when it comes to her journey with early breast cancer. The new mother and philanthropist discusses why she’s empowered to live a happy and healthy life.

Use precise geolocation data. Actively scan device characteristics for identification. Store and/or access information on a ...

The FDA has accepted a supplemental new drug application for the combination of darolutamide and androgen deprivation therapy for the treatment of patients with metastatic hormone-sensitive prostate ...

“We found that the probability of being alive and free of disease at two years was approximately 64% for cetuximab versus 51% ...